« No time for British clock changes | Main | AU Summit: Deal or No Deal »

One sleep disorder throws light on another

Treatment based on narcolepsy could promote sleep in insomniacs.

By learning from patients who nod off unexpectedly during the day, researchers have pinpointed a chemical that could help people who can't sleep at night.

One out of every 10 people in the United States suffers from chronic insomnia, making for a big sleeping-pill market. The most popular pills work by strengthening the effects of a brain chemical that slows the nervous system and promotes relaxation. But these drugs can also carry unpleasant side effects, including memory loss and grogginess the next day. The race for a better sleeping pill is still on.

Read the full story here.

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/1793

Comments

Narcoleptics fall asleep in REMsleep and not in nonREMsleep (as normally). What is th structure of sleep under Orexin inhibitors ?
Narcoleptics yawn frequently before a sleepy attaque. It is a gut alert symptom. Orexin inhibitors induce a loss of alertness and muscles tone . Is that a real sleep ?

Hi I heard a news report from a local radio station saying that in future insomnia could be a thing of the past, I Joined your mailing list and have access to the full article. This is not for me but for a good friend who has a very bad sleep pattern. When do you think this treatment will be available in Australia.

Hypocretin or orexins are also appetite stimulants -- in fact Yanigazawa’s group tested first in that direction. So an antagonist could have also some reduction in appetite and weight. Has that been tested in animals in the lab? Also as has been mentioned, Primary Insomnia is more a caffeine-like state -- are there other sympathetic measures that support the turn down of that hyper-alert effect?

Check it out another blog deals with all kinds of sleep disorders
http://www.aboutsleepdisorders.blogspot.com/

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.